Investor Presentaiton
154
Investor presentation Full year 2022
Novo Nordisk pledges to reach net-zero emissions across the
entire value chain by 2045
CO₂ emissions from scopes 1, 2 and 3 for full year 2022
1,000 tonnes CO2
2,041
86
75
75
77
15
16
76
16
2019
2020
2021
2022
2022
Scope 1
Scope 2
Scope 32
Targets:
Other³
•
2030: Zero emissions from operations and
transportation¹
•
2045: Net zero emissions across full value chain
Capital goods
Purchased goods
and services
Key initiatives to reduce CO2 emissions across all three scopes
Scope 1 - Direct emissions from own sources (12% reduction)4
Company cars: 100% electric or plug-in hybrid electric cars by 2030
Biogas: Conversion from natural gas to biogas in 2 production facilities
Scope 2 - Indirect emissions from purchased energy (79% reduction)4
Production: Sourcing 100% of renewable power at sites since 2020
Novo NordiskⓇ
Scope 3 - Other emissions across value chain
Suppliers: >400 key suppliers have committed to source renewable power
Product distribution: Alliances with Kuehne + Nagel and SkyNRG for
Sustainable Aviation Fuel that will reduce emissions from air transport
significantly
1 CO2 emissions from operations and transportation represents the emissions from production, offices and labs, cars, business flights and product distribution; 2 2022 is the first year of full Scope 3 emissions according to the Greenhouse Gas Protocol, which in
2021 was limited to product distribution and business flights. The calculation of Scope 3 emissions is substantially based on estimations and therefore inherently uncertain; 3 Full details available in the Novo Nordisk Annual Report 2022; c 2019 is used as
baseline across Scope 1 and 2.
Source: Novo Nordisk Annual Report 2022View entire presentation